These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32637107)

  • 1. A possible increase in liver enzymes due to amlodipine: A case report.
    Varghese G; Madi L; Ghannam M; Saad R
    SAGE Open Med Case Rep; 2020; 8():2050313X20917822. PubMed ID: 32637107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible amlodipine-induced hepatotoxicity after stem cell transplant.
    Hammerstrom AE
    Ann Pharmacother; 2015 Jan; 49(1):135-9. PubMed ID: 25239629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of probable oxybutynin-induced increase in liver enzymes.
    Alrawashdeh H; Madi L; Ahmed Elhada AH; Ahmed A; Serheed D
    Ther Clin Risk Manag; 2018; 14():1657-1660. PubMed ID: 30237720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury.
    García-Cortés M; Lucena MI; Pachkoria K; Borraz Y; Hidalgo R; Andrade RJ;
    Aliment Pharmacol Ther; 2008 May; 27(9):780-9. PubMed ID: 18284654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hepatitis associated with the use of levofloxacin.
    Figueira-Coelho J; Pereira O; Picado B; Mendonça P; Neves-Costa J; Neta J
    Clin Ther; 2010 Sep; 32(10):1733-7. PubMed ID: 21194596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of the Roussel Uclaf Causality Assessment Method (RUCAM) to analyze the hepatic findings in a clinical trial program: evaluation of the direct thrombin inhibitor ximelagatran.
    Lewis JH; Larrey D; Olsson R; Lee WM; Frison L; Keisu M
    Int J Clin Pharmacol Ther; 2008 Jul; 46(7):327-39. PubMed ID: 18793587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probable amlodipine-induced angioedema.
    Southward J; Irvine E; Rabinovich M
    Ann Pharmacother; 2009 Apr; 43(4):772-6. PubMed ID: 19299323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amlodipine-Induced Liver Injury.
    Yet Kwong Horman J; Patel P; Schultz M; Kraschnewski J
    Cureus; 2022 Mar; 14(3):e23441. PubMed ID: 35481325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hepatic injury associated with varenicline in a patient with underlying liver disease.
    Franck AJ; Sliter LR
    Ann Pharmacother; 2009 Sep; 43(9):1539-43. PubMed ID: 19638471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection.
    Paredes AH; Lewis JH
    Ann Pharmacother; 2007 May; 41(5):880-4. PubMed ID: 17426078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memantine-Induced Liver Injury With Probable Causality as Assessed Using the Roussel Uclaf Causality Assessment Method (RUCAM).
    Shumar J; Ordway S; Junga Z; Sadowski B; Torres D
    ACG Case Rep J; 2019 Aug; 6(8):e00184. PubMed ID: 31737715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperacute liver injury following intravenous fluconazole: A rare case of dose-independent hepatotoxicity.
    Gayam V; Khalid M; Dahal S; Garlapati P; Gill A
    J Family Med Prim Care; 2018; 7(2):451-454. PubMed ID: 30090793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection.
    Carrascosa MF; Lucena MI; Andrade RJ; Caviedes JR; Lavín AC; Mones JC; Rivero AP; Serrano VB
    Clin Ther; 2009 May; 31(5):1014-9. PubMed ID: 19539102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Case-Report of Drug-Induced Mixed Liver Injury Resulting From Cefepime Exposure.
    Malhotra K; Fazylov R; Friedman-Jakubovics M
    J Pharm Pract; 2023 Feb; 36(1):164-167. PubMed ID: 34098807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probable Enoxaparin-Induced Liver Injury in a Young Patient: A Case Report of a Diagnostic Challenge.
    Eze IE; Adidam S; Gordon DK; Lasisi OG; Gajjala J
    Cureus; 2023 Mar; 15(3):e36869. PubMed ID: 37123692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?
    Teschke R; Schulze J; Eickhoff A; Danan G
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug idiosyncrasy due to pirfenidone presenting as acute liver failure: Case report and mini-review of the literature.
    Verma N; Kumar P; Mitra S; Taneja S; Dhooria S; Das A; Duseja A; Dhiman RK; Chawla Y
    Hepatol Commun; 2018 Feb; 2(2):142-147. PubMed ID: 29404521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-Induced Liver Injury: An Institutional Case Series and Review of Literature.
    Gayam V; Khalid M; Shrestha B; Hossain MR; Dahal S; Garlapati P; Gill A; Mandal AK; Sangha R
    J Investig Med High Impact Case Rep; 2018; 6():2324709618761754. PubMed ID: 29568780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amlodipine-induced bilateral upper extremity edema.
    Ganeshalingham A; Wong W
    Ann Pharmacother; 2007 Sep; 41(9):1536-8. PubMed ID: 17666572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Montelukast induced acute hepatocellular liver injury.
    Harugeri A; Parthasarathi G; Sharma J; D'Souza GA; Ramesh M
    J Postgrad Med; 2009; 55(2):141-2. PubMed ID: 19550064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.